Cyprus · Delayed Price · Currency is EUR IDNA Genomics Public Statistics
Total Valuation
CYS:IDNA has a market cap or net worth of EUR 57.97 million. The enterprise value is 60.08 million.
| Market Cap | 57.97M |
| Enterprise Value | 60.08M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
CYS:IDNA has 2.76 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 2.76M |
| Shares Outstanding | 2.76M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 85.00% |
| Owned by Institutions (%) | n/a |
| Float | 414,050 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 117.76 |
| PB Ratio | -13.76 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 122.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.19
| Current Ratio | 0.19 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -11.67 |
| Interest Coverage | -10.98 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -67.17% |
| Return on Invested Capital (ROIC) | -356.26% |
| Return on Capital Employed (ROCE) | 74.80% |
| Weighted Average Cost of Capital (WACC) | 5.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.25 |
| Inventory Turnover | 2.23 |
Taxes
In the past 12 months, CYS:IDNA has paid 25,049 in taxes.
| Income Tax | 25,049 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.46% in the last 52 weeks. The beta is 0.19, so CYS:IDNA's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | -24.46% |
| 50-Day Moving Average | 28.64 |
| 200-Day Moving Average | 26.64 |
| Relative Strength Index (RSI) | 31.59 |
| Average Volume (20 Days) | 1,492 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CYS:IDNA had revenue of EUR 492,252 and -2.24 million in losses. Loss per share was -0.81.
| Revenue | 492,252 |
| Gross Profit | -129,749 |
| Operating Income | -2.15M |
| Pretax Income | -3.44M |
| Net Income | -2.24M |
| EBITDA | -1.99M |
| EBIT | -2.15M |
| Loss Per Share | -0.81 |
Balance Sheet
The company has 11,862 in cash and 2.92 million in debt, with a net cash position of -2.91 million or -1.05 per share.
| Cash & Cash Equivalents | 11,862 |
| Total Debt | 2.92M |
| Net Cash | -2.91M |
| Net Cash Per Share | -1.05 |
| Equity (Book Value) | -4.21M |
| Book Value Per Share | -1.13 |
| Working Capital | -3.25M |
Cash Flow
In the last 12 months, operating cash flow was -245,833 and capital expenditures -4,369, giving a free cash flow of -250,202.
| Operating Cash Flow | -245,833 |
| Capital Expenditures | -4,369 |
| Depreciation & Amortization | 159,772 |
| Net Borrowing | 101,395 |
| Free Cash Flow | -250,202 |
| FCF Per Share | -0.09 |
Margins
| Gross Margin | -26.36% |
| Operating Margin | -436.22% |
| Pretax Margin | -698.45% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CYS:IDNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | -3.86% |
| FCF Yield | -0.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CYS:IDNA has an Altman Z-Score of -4.31 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.31 |
| Piotroski F-Score | 1 |